EP1244769A1 - Production of peptides by fedbatch cultivation of a microorganism - Google Patents

Production of peptides by fedbatch cultivation of a microorganism

Info

Publication number
EP1244769A1
EP1244769A1 EP00982029A EP00982029A EP1244769A1 EP 1244769 A1 EP1244769 A1 EP 1244769A1 EP 00982029 A EP00982029 A EP 00982029A EP 00982029 A EP00982029 A EP 00982029A EP 1244769 A1 EP1244769 A1 EP 1244769A1
Authority
EP
European Patent Office
Prior art keywords
glucose
oscillation
cultivation
feed
carbon source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00982029A
Other languages
German (de)
French (fr)
Inventor
Andreas Castan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of EP1244769A1 publication Critical patent/EP1244769A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C07K14/615—Extraction from natural sources

Definitions

  • the invention relates to a method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts.
  • the cultivation is carried out by the addition of the organic carbon source by oscillation feed and/or by oscillation variation of stirring speed, e.g. in a square or sinus wave pattern.
  • the organic carbon source is glucose and the recombinant peptide is growth hormone.
  • hGH human growth hormone
  • tPA tissue plasminogen activator
  • concentration When scaling up bioprocesses, differences in the micro-environment, such as concentration, and gradients, are likely to be expected. Concentration gradients of substrates, such as the carbon source added at limiting feed (fedbatch), ammonia for pH titration and oxygen, are to be expected as the result of changing geometry and process parameters as well as the choice of feed position. Most organisms respond to rapid environmental changes and can also change their metabolism in a time- scale of seconds or less.
  • Pulse addition of glucose and the oscillating glucose concentration within the fermentor have earlier been studied with regard to yield and expression. Pulse addition of glucose, i.e. addition of glucose within a few seconds when the culture had reached the steady state, was shown to induce gapA gene expression strongly and very rapidly (Gschaedler, Anne; et al, Biotechnol. Bioeng. (1999), 63(6), 712-720). The effect of oscillating glucose concentration within the fermentor on biomass yield and acetate formation has been studied. The conclusion was, that the lower biomass yield and the higher acetate formation were caused by the cell response to the glucose oscillation within the fermentor when comparing large and small scale cultivations. (Bylund, F et al, Bioprocess Eng. (1999), 20(5), 377-389).
  • Pulse addition of the growth substrate (glucose) at appropriate time intervals allowing for significant starvation period between two consecutive pulses during fed-batch cultivation have positive effects on stabilizing plasmid and enhancing protein production.
  • the pulse addition was repeated for 4-5 times at about 6 hours intervals. The result shows that the periodic glucose starvation feeding strategy can maintain a stable plasmid-carrying cell fraction and a stable specific productivity of the recombinant protein.
  • US 5912133 discloses a fed-batch cultivation, wherein the carbon source concentration is at a constant low level under 5g/L and wherein the carbon source is added in at least two feedings. The carbon source should be exhausted after the first feeding and before the second feeding.
  • the most applied technique to achieve high cell densities is the glucose-limited fed-batch.
  • all media components are supplied in excess as in a batch process, except for example the carbon source.
  • a feed with a substrate solution often glucose, is fed to the bioreactor with a rate that ensures that this substrate component is growth limiting.
  • This substrate limitation allows control of the growth rate and the sugar uptake.
  • engineering limitations such as excessive heat evolution and oxygen limitation can be avoided.
  • Glucose uptake can be divided in three reactions, glucose that is used for anabolism, glucose consumption for maintenance, which is the housekeeping requirement of the cell and glucose consumption to fuel growth. The yield in the last two reactions is approximately 1.07 g 02 g '!
  • Figure 1 shows mode of operation
  • Figure 2 shows % amount of rhGH calculated on standard.
  • Figure 3 shows % of rhGH variants.
  • the invention relates to a method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. This includes also a complex cultivation media.
  • cultivation of a microorganism is meant cultivation of a biological host such as bacteria, yeast or animal cell.
  • the cultivation is carried out by the addition of the organic carbon source in oscillation feed and/or by oscillation variation of stirring speed.
  • the oscillation feed and/or the oscillation variation of stirring speed can be performed during the entire cultivation process or during the production phase after the induction of the recombinant protein.
  • the oscillation feed can have a square wave or sinus wave pattern. No starvation should occur during the oscillation period.
  • the glucose added is consumed by the cells, but not until total starvation.
  • the carbon source should never be exhausted during the process and there is no need for measuring its concentration during cultivation.
  • the density of the cells should be high, preferably above 10 g/L and more preferably above 20 g/L and even more preferably above 50 g/L during cultivation. However, aerobic conditions should be maintained.
  • the biomass concentration in the experiments was in of the order of 40 g/L.
  • the organic carbon source is glucose and the recombinant peptide is preferably growth hormone.
  • the period time for the oscillation curve can easily be determined for each protein, type of cultivation, medium etc by a person skilled in the art.
  • the period for the oscillation time can be e.g. a short time of one minute as exemplified here, but periods of five, 10 , 30 minutes or longer periods are also within the scope of the invention.
  • the amplitude can be varied from about ⁇ 5 % up to ⁇ 100 %, e.g. ⁇ 20, ⁇ 30, ⁇ 40, ⁇ 50 or ⁇ 60%, which also easily is to be determined by a person skilled in the art.
  • Oscillation periods can be interrupted by periods of constant glucose addition or constant stirring speed.
  • the addition of glucose is here illustrated as a square wave function.
  • the sinus wave function is especially suitable for the stirring speed. Also variation between sinus and square can be used.
  • the concentration of the carbon source and oxygen changes proportionally with the oscillation of the feed and agitation, respectively.
  • the influence of substrate feed on the quality of a recombinant protein produced by Escherichia coli has specifically been studied in the production of recombinant human growth hormone (rhGH)in an aerobic fed-batch process as a model system.
  • rhGH human growth hormone
  • Escherichia coli (W3110) with a pBR derived plasmid coding for recombinant human growth hormone (rhGH) and antibiotic resistance was used in the performed cultivations.
  • This rhGH form is a 22 kDa protein consisting of 191 amino acids with two intramolecular disulphide bridges. The protein is secreted to the periplasm where the disulphide bridges are formed.
  • the feed solution had a glucose concentration of 590 g/1.
  • the inoculum volume was about 10 % of final total volume. After the transfer procedure the glucose feed was immediately started.
  • the feed profile consisted of three different phases: firstly, there was an exponential feed phase; secondly, the feed was turned to constant rate when the estimated maximum oxygen transfer capacity of the bioreactor was approached and finally the feed rate was decreased to 80 % of its maximum value at the time for induction.
  • Figure 2 shows the amount of rhGH when rhGH is prepared by the different methods. It is clear from the experiment that the amount of rhGH was much higher when glucose was added in an oscillation feed and by oscillation variation of stirring speed.
  • Figure 3 shows the amount in % of total of rhGH 22kDa, i.e. the proper form of rhGH (black) and the amount of clipped variants (white) when the methods (a), (b) and (c) are used. It can be seen that the yield of the proper form of rhGH, i.e. 22 kDa is higher when glucose was added in an oscillation feed and by oscillation variation of stirring speed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to a method for the production of recombinant peptides by fedbatch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. The cultivation is carried out by the addition of the organic carbon source by oscillation feed and/or by oscillation variation of stirring speed, e.g. in a square or sinus wave pattern. Preferably the organic carbon source is glucose and the recombinant peptide is growth hormone.

Description

P roduc t i on of pept i des by fed ba tch cu l t i va t i on of a m i c roo rgan i sm .
The invention relates to a method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. The cultivation is carried out by the addition of the organic carbon source by oscillation feed and/or by oscillation variation of stirring speed, e.g. in a square or sinus wave pattern. Preferably the organic carbon source is glucose and the recombinant peptide is growth hormone.
BACKGROUND
Recombinant human proteins have become important pharmaceuticals. The combination of recombinant DNA technology and large-scale processes has enabled production of proteins that might otherwise have been impossible or too expensive to obtain from natural sources. For instance human growth hormone (hGH), immune interferon, tissue plasminogen activator (tPA) and human insulin are now commercial available by recombinant DNA technology.
However, the organism in large-scale bioprocesses is exposed to a changing environment and also respond to this. Differences in the production of recombinant proteins have been observed when increasing the reactor size. E.g. Riesenberg D et al. in Appl Microbiol Biotechnol 34:77-82, 1990, showed that the amount of human interferon alpha 1 was reduced by a factor of two when the culture volume was increased from 15 to 250 L.
When scaling up bioprocesses, differences in the micro-environment, such as concentration, and gradients, are likely to be expected. Concentration gradients of substrates, such as the carbon source added at limiting feed (fedbatch), ammonia for pH titration and oxygen, are to be expected as the result of changing geometry and process parameters as well as the choice of feed position. Most organisms respond to rapid environmental changes and can also change their metabolism in a time- scale of seconds or less.
Pulse addition of glucose and the oscillating glucose concentration within the fermentor have earlier been studied with regard to yield and expression. Pulse addition of glucose, i.e. addition of glucose within a few seconds when the culture had reached the steady state, was shown to induce gapA gene expression strongly and very rapidly (Gschaedler, Anne; et al, Biotechnol. Bioeng. (1999), 63(6), 712-720). The effect of oscillating glucose concentration within the fermentor on biomass yield and acetate formation has been studied. The conclusion was, that the lower biomass yield and the higher acetate formation were caused by the cell response to the glucose oscillation within the fermentor when comparing large and small scale cultivations. (Bylund, F et al, Bioprocess Eng. (1999), 20(5), 377-389).
Pulse addition of the growth substrate (glucose) at appropriate time intervals allowing for significant starvation period between two consecutive pulses during fed-batch cultivation have positive effects on stabilizing plasmid and enhancing protein production. (Cheng, Chinyuan et al.Biotechnol. Bioeng. (1997), 56(1), 23-31). The pulse addition was repeated for 4-5 times at about 6 hours intervals. The result shows that the periodic glucose starvation feeding strategy can maintain a stable plasmid-carrying cell fraction and a stable specific productivity of the recombinant protein. On the contrary, without glucose starvation, the fraction of plasmid-carrying cells and the specific productivity continue to drop during the fed-batch cultivation, which would greatly reduce the product yield and limit the duration that the cultivation can be effectively operated. Wang, Zhengjun et al. Biotechnol. Bioeng. (1993), 42(1), 95-102 have shown that a glucose pulse at the end of batch culture in YPD (rich complex medium) facilitated the transport of residual cytoplasmic invertase.
US 5912133 discloses a fed-batch cultivation, wherein the carbon source concentration is at a constant low level under 5g/L and wherein the carbon source is added in at least two feedings. The carbon source should be exhausted after the first feeding and before the second feeding.
It is also known to use external magnetic field with periodic variations and product stirring movement in a cell culture vessel. (DD271850). Thereby introduced material is effectively distributed with no local and potentially damaging concentrations
None of the reports disclose a repeated oscillation of organic carbon source in a square or sinus wave pattern, which can be characterized by amplitude and frequency. On the contrary it can be concluded from prior art that there should be a significant starvation period between two consecutive feedings (Cheng et al.) or that that a glucose pulse should only be done at the end of batch culture (Wang et al.).
The most applied technique to achieve high cell densities is the glucose-limited fed-batch. In a fed-batch process, all media components are supplied in excess as in a batch process, except for example the carbon source. A feed with a substrate solution, often glucose, is fed to the bioreactor with a rate that ensures that this substrate component is growth limiting. This substrate limitation allows control of the growth rate and the sugar uptake. By limiting the sugar uptake and thereby the reaction rate, engineering limitations, such as excessive heat evolution and oxygen limitation can be avoided. Glucose uptake can be divided in three reactions, glucose that is used for anabolism, glucose consumption for maintenance, which is the housekeeping requirement of the cell and glucose consumption to fuel growth. The yield in the last two reactions is approximately 1.07 g02 g'! sugar- Control of the growth rate can therefore be used to control the oxygen consumption and heat generation associated with growth. Furthermore, substrate limitation permits metabolic control by which overflow metabolism (i.e. acetate formation in case of E. coli) and catabolite repression can be avoided. In the baker's yeast process sugar limitation is used throughout the process to avoid over-flow metabolism that results in excessive ethanol production (George et al. (1998). Bioprocess Eng 18: 135-142.). Inhibitory acetate production by E. coli is avoided in the same way (See e.g. Lee, S. Y. (1996). Trends Biotechnol 14: 98-105). In the production of recombinant proteins the oxygen transfer and the dissolved oxygen tension is particularly important for the yield and quality of the product (See e.g. Bhattacharya and Dubey (1997) Enzyme Microb Technol 20: 355-360).A fed-batch process is therefore often the first choice when designing high-cell-density processes in E. coli.
FIGURES
Figure 1 shows mode of operation Figure 2 shows % amount of rhGH calculated on standard. Figure 3 shows % of rhGH variants.
THE INVENTION We have to our great surprise found that when the glucose feed was varied in oscillation feed and/or the stirring speed was performed in oscillation variation in a fed-batch cultivation, improved rhGH quality and yield i.e. less amount of not wanted products, was obtained. The word oscillation used here can also be described as pulses or by up and down-shifts. The invention relates to a method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. This includes also a complex cultivation media. By the expression cultivation of a microorganism is meant cultivation of a biological host such as bacteria, yeast or animal cell.
The cultivation is carried out by the addition of the organic carbon source in oscillation feed and/or by oscillation variation of stirring speed. The oscillation feed and/or the oscillation variation of stirring speed can be performed during the entire cultivation process or during the production phase after the induction of the recombinant protein. The oscillation feed can have a square wave or sinus wave pattern. No starvation should occur during the oscillation period. The glucose added is consumed by the cells, but not until total starvation. The carbon source should never be exhausted during the process and there is no need for measuring its concentration during cultivation. The density of the cells should be high, preferably above 10 g/L and more preferably above 20 g/L and even more preferably above 50 g/L during cultivation. However, aerobic conditions should be maintained. The biomass concentration in the experiments was in of the order of 40 g/L. Preferably the organic carbon source is glucose and the recombinant peptide is preferably growth hormone.
The period time for the oscillation curve can easily be determined for each protein, type of cultivation, medium etc by a person skilled in the art. The period for the oscillation time can be e.g. a short time of one minute as exemplified here, but periods of five, 10 , 30 minutes or longer periods are also within the scope of the invention. The amplitude can be varied from about ± 5 % up to ± 100 %, e.g. ± 20, ± 30, ± 40, ± 50 or ± 60%, which also easily is to be determined by a person skilled in the art. Oscillation periods can be interrupted by periods of constant glucose addition or constant stirring speed. The addition of glucose is here illustrated as a square wave function. The sinus wave function is especially suitable for the stirring speed. Also variation between sinus and square can be used.
According to our invention, the concentration of the carbon source and oxygen changes proportionally with the oscillation of the feed and agitation, respectively. The influence of substrate feed on the quality of a recombinant protein produced by Escherichia coli has specifically been studied in the production of recombinant human growth hormone (rhGH)in an aerobic fed-batch process as a model system. Our invention and the findings are further confirmed in Bylund, Castan, Mikkola, Neide and Larsson; Biotechnology and Bioengineering 69 (2), 119-128 (2000).
MATERIAL AND METHODS
Organism and Medium
Escherichia coli (W3110) with a pBR derived plasmid coding for recombinant human growth hormone (rhGH) and antibiotic resistance was used in the performed cultivations.
This rhGH form is a 22 kDa protein consisting of 191 amino acids with two intramolecular disulphide bridges. The protein is secreted to the periplasm where the disulphide bridges are formed.
Cultivations were performed in a glucose mineral salt medium. The media used, with some minor modifications, is described by Forsberg G et al. in J. Biol. Chem. 272 (1997) 12430-
12438
Media components together with distilled water were sterilised in the bioreactor at 121 °C.
After sterilisation, sterilised magnesium sulphate, trace elements and antibiotics were added separately. Breox was added when needed for foam control. The feed solution had a glucose concentration of 590 g/1.
Cultivation Procedure and Bioreactors
Exponentially growing cells from the seed fermentor were transferred to the production bioreactor. The inoculum volume was about 10 % of final total volume. After the transfer procedure the glucose feed was immediately started. The feed profile consisted of three different phases: firstly, there was an exponential feed phase; secondly, the feed was turned to constant rate when the estimated maximum oxygen transfer capacity of the bioreactor was approached and finally the feed rate was decreased to 80 % of its maximum value at the time for induction.
The addition of glucose was made as a square wave function that was superimposed to the standard feed as illustrated in Figure 1.
Temperature and pH were controlled near the optimal value for E.coli growth. All cultivations were performed in a 15 1 CF 3000 Chemap-Fermenter (Switzerland) stirred tank reactor (STR) with a start volume of 7 1. The volume increased during the feed phase up to 9 1.
Analytical Procedures.
Samples for product analyses were achieved from the extraction of the pellet fraction of 5 ml centrifiiged cell suspension. This extraction method releases the periplasmic fraction of proteins. Centrifugation was performed at 5000 rpm for 15 min at +4°C. Extraction buffer consisted of (per litre): Tris-HCl, 0.9837 g; Tris-base, 0.4551 g; EDTAx2H2O, 0.372 g. Purity and quantity of rhGH were determined by hydrophobic interaction chromatography (HIC). HIC was performed on a TSK phenyl 5PW column, Tosoh Haas. Four different variants of rhGH are separated by a decreasing salt gradient and detected with UV at 230 ran: (des-Phel)-rhGH (LMW), rhGH, (trisulfide Cysl82-Cysl89)-rhGH and clipped 142/143-rhGH (clipped variant).
RESULTS
The result is shown in Figures 2 and 3. In the Figures 1-3, rhGH is produced (a) by a standard method
(b) by a glucose feed that follow a square wave with an amplitude of ± 30% of the standard value and a frequency of 1 minute and (c) by a standard glucose feed but an stirring profile (at a rate of 800 - 1200 rpm) that follow a square wave with an amplitude of + 20% and a frequency of 1 minute.
Figure 2 shows the amount of rhGH when rhGH is prepared by the different methods. It is clear from the experiment that the amount of rhGH was much higher when glucose was added in an oscillation feed and by oscillation variation of stirring speed.
Figure 3 shows the amount in % of total of rhGH 22kDa, i.e. the proper form of rhGH (black) and the amount of clipped variants (white) when the methods (a), (b) and (c) are used. It can be seen that the yield of the proper form of rhGH, i.e. 22 kDa is higher when glucose was added in an oscillation feed and by oscillation variation of stirring speed.
CONCLUSIONS
Optimisation of the glucose feeding strategy or stirring profile by using oscillation in square or sinus wave pattern gives the advantages that the yield of the protein is higher, that proteolysis could be avoided at a higher level and that the purification thereby is easier than when the organic source is fed without oscillation feed.

Claims

1. Method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen
10 source and mineral salts in which the cultivation is carried out by the addition of the organic carbon source in oscillation feed and/or by oscillation variation of stirring speed.
2. Method according to claim 1 in which the organic carbon is glucose.
153. Method according to claim 1 or 2 in which the microorganism is E. Coli.
4. Method according to any of claims 1 to 3 in which the oscillation feed has a square wave pattern.
205. Method according to any of claims 1 to 3 in which the oscillation feed has sinus wave patters.
6. Method according any of claims 1 to 5 in which the recombinant peptide is growth hormone.
25
7. Method according any of claims 1 to 6 in which the recombinant peptide is human growth hormone
EP00982029A 1999-12-09 2000-11-29 Production of peptides by fedbatch cultivation of a microorganism Withdrawn EP1244769A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904502A SE9904502D0 (en) 1999-12-09 1999-12-09 Production of peptides
SE9904502 1999-12-09
PCT/SE2000/002373 WO2001042420A1 (en) 1999-12-09 2000-11-29 Production of peptides by fedbatch cultivation of a microorganism

Publications (1)

Publication Number Publication Date
EP1244769A1 true EP1244769A1 (en) 2002-10-02

Family

ID=20418057

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00982029A Withdrawn EP1244769A1 (en) 1999-12-09 2000-11-29 Production of peptides by fedbatch cultivation of a microorganism

Country Status (10)

Country Link
EP (1) EP1244769A1 (en)
JP (1) JP2003516140A (en)
KR (1) KR20020060258A (en)
CN (1) CN1267562C (en)
AU (1) AU780122B2 (en)
CA (1) CA2392268A1 (en)
IL (1) IL149624A0 (en)
NZ (1) NZ518919A (en)
SE (1) SE9904502D0 (en)
WO (1) WO2001042420A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003272585B2 (en) * 2002-09-20 2009-12-10 Pharmacia Corporation Process for decreasing aggregate levels of pegylated protein
TWI281864B (en) * 2002-11-20 2007-06-01 Pharmacia Corp N-terminally monopegylated human growth hormone conjugates and process for their preparation
ATE394473T1 (en) * 2004-12-21 2008-05-15 Usv Ltd FERMENTATION PROCESS WITH LOW CELL DENSITY FOR THE PRODUCTION OF HETEROLOGUE RECOMBINANT PROTEINS IN MICROORGANISMS
EP2041262A4 (en) * 2006-07-14 2012-07-18 Abb Research Ltd METHOD FOR ONLINE OPTIMIZATION OF A DISCONTINUOUS FLOW FERMENTATION UNIT FOR OPTIMIZATION OF PRODUCTIVITY
BR112013008103B1 (en) * 2010-09-21 2021-01-26 Ferring B.V. process for the production of human growth hormone (hgh) and method for reducing the amount of polymeric forms of hgh during a process for the production of hgh
CN106222309A (en) * 2016-07-28 2016-12-14 山东金朗生物科技有限公司 A kind of fermentable produces the control of additive raw material method improving L alanine yield
CN108624516B (en) * 2017-03-20 2022-08-26 华东理工大学 Method for improving metabolite amount in fermentation cells and preparing IDMS standard substance
GB202010934D0 (en) * 2020-07-15 2020-08-26 Ipsen Biopharm Ltd Controlling operation of a bioreactor vessel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD271850A1 (en) * 1988-05-12 1989-09-20 Adw Ddr MIXING DEVICE FOR FLUID DISTRIBUTION AND / OR FOR GAS ADMISSION IN BIOLOGICAL CULTURAL SUSPENSIONS WITH PENDULUM ROTORS
BR9105208A (en) * 1990-11-30 1992-07-21 Ajinomoto Kk PROCESS FOR AEROBIC CULTIVATION OF A MICROORGANISM IN A Batch-fed CULTURE, CONTINUOUS CULTURE OR CONTINUOUS CULTURE CULTURE, APPLIANCE TO CONTROL THE CONCENTRATION OF THE SUBSTRATE CARBON SOURCE AND PROCESS TO PRODUCE LIS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0142420A1 *

Also Published As

Publication number Publication date
KR20020060258A (en) 2002-07-16
IL149624A0 (en) 2002-11-10
AU780122B2 (en) 2005-03-03
HK1053326A1 (en) 2003-10-17
WO2001042420A1 (en) 2001-06-14
CA2392268A1 (en) 2001-06-14
CN1267562C (en) 2006-08-02
AU1910501A (en) 2001-06-18
SE9904502D0 (en) 1999-12-09
NZ518919A (en) 2003-10-31
JP2003516140A (en) 2003-05-13
CN1409755A (en) 2003-04-09

Similar Documents

Publication Publication Date Title
US6680181B2 (en) Production of peptides
CN101983242B (en) Fermentation medium containing urea nitrogen source and its use for the production of recombinant protein
Wong et al. Effect of post‐induction nutrient feeding strategies on the production of bioadhesive protein in Escherichia coli
Tabandeh et al. Heat-induced production of human growth hormone by high cell density cultivation of recombinant Escherichia coli
AU780122B2 (en) Production of peptides by fedbatch cultivation of a microorganism
Yim et al. High-level secretory production of human granulocyte-colony stimulating factor by fed-batch culture of recombinant Escherichia coli
US20060127975A1 (en) Method for culturing cells in order to produce substances
ES2191064T5 (en) PROCEDURE TO PRODUCE PROTEINS.
AU775301B2 (en) Method for increasing the yield of recombinant proteins in microbial fermentation processes
JPWO1996012816A1 (en) Protein production methods
Delacruz et al. Bioprocess development to improve foreign protein production from recombinant Streptomyces
EA022946B1 (en) Process for obtaining aspart insulin using a pichia pastoris yeast strain
EP1828375B1 (en) Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms
CA3148183C (en) Escherichia coli-based recombinant strain, construction method therefor and use thereof
HK1053326B (en) Production of peptides by fedbatch cultivation of a microorganism
US12522838B2 (en) Promoter for yeast
Aeini Evaluating the impact of different engineered E. coli strains on Recombinant IGF-I production
CN118373922A (en) Application of soluble tag protein in preparation of semaglutin main chain
WO2024261777A1 (en) Expression cassettes for protein expression, method(s) and application(s) thereof
Hoxha Defined and Complex Medium Based Feeding Strategy Development for Recombinant Human Growth Hormone Production by P. PastorisUnder Gap Promoter
US20060286631A1 (en) Method for preparating t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene
HK1052029B (en) Method for increasing the yield of recombinant proteins in microbial fermentation processes
Muth Drug Manufacture
Boström Design of substrate induced transcription for control of recombinant protein production in Escherichia coli
Moghaddam et al. Faculty of Pharmacy Tabriz University of Medical Sciences Research Center for Molecular Medicine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020523

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL PAYMENT 20020523;LT PAYMENT 20020523;LV PAYMENT 20020523;MK PAYMENT 20020523;RO PAYMENT 20020523;SI PAYMENT 20020523

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PFIZER HEALTH AB

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080603